The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from Atopic Dermatitis patients

aureus Dermatitis The association between disease activity and S. aureus means that antimicrobials are frequently used in AD patients. Increasingly it is becoming evident that there are specific lineages seemingly adapted to colonising and surviving on AD affected skin 19 . This analysis has demonstrated differences in genetic backgrounds of S. aureus colonising AD cases compared with controls, and a marked difference in the prevalence of topical antimicrobial resistance determinants amongst children with AD.

[1]  L. Pardo,et al.  IgG response against Staphylococcus aureus is associated with severe atopic dermatitis in children , 2018, The British journal of dermatology.

[2]  Y. Grad,et al.  Trends in Antibiotic Susceptibility in Staphylococcus aureus in Boston, Massachusetts, from 2000 to 2014 , 2017, Journal of Clinical Microbiology.

[3]  T. Agner,et al.  Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations , 2017, The British journal of dermatology.

[4]  J. Parkhill,et al.  The Microevolution and Epidemiology of Staphylococcus aureus Colonization during Atopic Eczema Disease Flare , 2017, The Journal of investigative dermatology.

[5]  A. Tomasz,et al.  Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice , 2017, Genome Biology.

[6]  T. Mustelin,et al.  The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies , 2017, The British journal of dermatology.

[7]  S. Kežić,et al.  Clumping Factor B Promotes Adherence of Staphylococcus aureus to Corneocytes in Atopic Dermatitis , 2017, Infection and Immunity.

[8]  H. Williams,et al.  What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials , 2017, The British journal of dermatology.

[9]  K. Hood,et al.  Oral and Topical Antibiotics for Clinically Infected Eczema in Children: A Pragmatic Randomized Controlled Trial in Ambulatory Care , 2017, The Annals of Family Medicine.

[10]  S. Pasmans,et al.  Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta‐analysis , 2016, The British journal of dermatology.

[11]  P. Ong,et al.  Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review , 2016, Clinical Reviews in Allergy & Immunology.

[12]  Jukka Corander,et al.  Whole-Genome Sequencing for Routine Pathogen Surveillance in Public Health: a Population Snapshot of Invasive Staphylococcus aureus in Europe , 2016, mBio.

[13]  D. Redoules,et al.  Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis. , 2016, The Journal of allergy and clinical immunology.

[14]  Ronald N. Jones,et al.  Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014 , 2016, Antimicrobial Agents and Chemotherapy.

[15]  K. Hood,et al.  A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: the ChildRen with Eczema, Antibiotic Management (CREAM) study. , 2016, Health technology assessment.

[16]  J. Kwong,et al.  Rapid Emergence and Evolution of Staphylococcus aureus Clones Harboring fusC-Containing Staphylococcal Cassette Chromosome Elements , 2016, Antimicrobial Agents and Chemotherapy.

[17]  Justin Zobel,et al.  SRST2: Rapid genomic surveillance for public health and hospital microbiology labs , 2014, bioRxiv.

[18]  A. T. Freitas,et al.  Evaluation of Reduced Susceptibility to Quaternary Ammonium Compounds and Bisbiguanides in Clinical Isolates and Laboratory-Generated Mutants of Staphylococcus aureus , 2013, Antimicrobial Agents and Chemotherapy.

[19]  Herman Goossens,et al.  Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study. , 2013, The Lancet. Infectious diseases.

[20]  M. Wilcox,et al.  Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? , 2012, The Journal of antimicrobial chemotherapy.

[21]  Ronald N. Jones,et al.  Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008). , 2010, The Journal of antimicrobial chemotherapy.

[22]  H. Williams,et al.  Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review , 2010, The British journal of dermatology.

[23]  W. Lo,et al.  Comparative molecular analysis of meticillin‐resistant Staphylococcus aureus isolates from children with atopic dermatitis and healthy subjects in Taiwan , 2010, The British journal of dermatology.

[24]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.

[25]  D. Hughes,et al.  Genetic and Phenotypic Identification of Fusidic Acid-Resistant Mutants with the Small-Colony-Variant Phenotype in Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.

[26]  C. Palmer,et al.  Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use. , 2007, International journal of antimicrobial agents.

[27]  Alex van Belkum,et al.  The role of nasal carriage in Staphylococcus aureus infections. , 2005, The Lancet. Infectious diseases.

[28]  T. Wichelhaus,et al.  Compensatory Adaptation to the Loss of Biological Fitness Associated with Acquisition of Fusidic Acid Resistance in Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.

[29]  B. Barrell,et al.  Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Mohanraj,et al.  High levels of fusidic acid‐resistant Staphylococcus aureus in dermatology patients , 2003, The British journal of dermatology.

[31]  R. Hay,et al.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. , 1994, The British journal of dermatology.

[32]  D. Hill.  Statistics with Confidence: Confidence Intervals and Statistical Guidelines , 1990 .

[33]  J. Parkhill,et al.  International Journal of Antimicrobial Agents Emergent and Evolving Antimicrobial Resistance Cassettes in Community-associated Fusidic Acid and Meticillin-resistant Staphylococcus Aureus , 2022 .